Genotoxicity assessment of 1,4-anhydro-4-seleno-D-talitol (SeTal) in human liver HepG2 and HepaRG cells.

MLA

di Vito, Raffaella, et al. “Genotoxicity Assessment of 1,4-Anhydro-4-Seleno-D-Talitol (SeTal) in Human Liver HepG2 and HepaRG Cells.” Toxicology, vol. 499, Nov. 2023, p. 153663. EBSCOhost, https://doi.org/10.1016/j.tox.2023.153663.

APA

di Vito, R., Acito, M., Fatigoni, C., Schiesser, C. H., Davies, M. J., Mangiavacchi, F., Villarini, M., Santi, C., & Moretti, M. (2023). Genotoxicity assessment of 1,4-anhydro-4-seleno-D-talitol (SeTal) in human liver HepG2 and HepaRG cells. Toxicology, 499, 153663. https://doi.org/10.1016/j.tox.2023.153663

Chicago

di Vito, Raffaella, Mattia Acito, Cristina Fatigoni, Carl H Schiesser, Michael J Davies, Francesca Mangiavacchi, Milena Villarini, Claudio Santi, and Massimo Moretti. 2023. “Genotoxicity Assessment of 1,4-Anhydro-4-Seleno-D-Talitol (SeTal) in Human Liver HepG2 and HepaRG Cells.” Toxicology 499 (November): 153663. doi:10.1016/j.tox.2023.153663.